21 Sep 2022

Nufarm appoints Alexandra Gartmann as Non-executive director

The Board of Nufarm is pleased to announce that Ms Alexandra Gartmann will be appointed as a Non-executive director of the Nufarm Board with effect from 23 September 2022. Ms Gartmann will stand for election at Nufarm’s Annual General Meeting in February 2023. Nufarm Chair, John Gillam said Ms Gartmann’s appointment followed an extensive search ...

13 Sep 2022

Nuseed expands its bioenergy platform; acquires assets and signs long-term alliance with GranBio to accelerate global expansion of energy cane

We are pleased to announce that Nuseed and GranBio a long-term global cooperation agreement to accelerate energy cane R&D and global expansion. This deal secures feedstock at large scale for future SAF and 2G biomass based biorefineries.  Nuseed and GranBio have entered into a long-term strategic alliance to accelerate R&D and commercialization into global energy ...

12 Sep 2022

Vale Her Majesty Queen Elizabeth II

HER MAJESTY QUEEN ELIZABETH II 21st April, 1926 – 8th September, 2022 At Nufarm we are deeply saddened by the news of her Majesty the Queen’s death. She was a remarkable woman, a much loved and hugely respected monarch who reigned over the United Kingdom and its Commonwealth for over 70 years. To so many ...

09 Sep 2022

Nufarm expands its bioenergy platform; acquires assets and signs long term alliance with GranBio to accelerate global expansion of energy cane

Nufarm group has acquired energy cane assets and entered into a long-term technology access and license agreement with GranBio Investimentos SA (GranBio) group, a leading Brazilian industrial biotechnology group, to accelerate the development and global expansion of energy cane. The Nufarm group has acquired GranBio group’s energy cane production assets, including germplasm, breeding materials and ...

28 Jul 2022

Nufarm increases its investment and expands partnership with crop health company, Enko.

On expanding Nufarm’s partnership, Nufarm Managing Director and CEO Greg Hunt said “Nufarm aims to bring the latest seed and chemical technologies to bear in the field, helping our customers overcome crop threats and be able to ‘grow a better tomorrow’—which impacts all of us. We were early investors in Enko and have followed the ...

14 Jun 2022

Valent and Nufarm Extend Canada Distribution Relationship

Guelph, ON and Calgary, AB, June 14, 2022 – Valent Canada Inc. and Nufarm Agriculture Inc. announced today a five-year extension of their distribution relationship in Canada. The Valent-Nufarm collaboration has been active in Canada since 2011, providing a growing portfolio of herbicides, insecticides, fungicides, plant growth regulators and seed treatments through Nufarm’s established distribution ...

08 Jun 2022

Bell Potter Home Grown Conference 2022

Nufarm CEO, Greg Hunt presented at the Bell Potter Home Grown Conference on the 8th June 2022. Click here to read the presentation.  

01 Jun 2022

Resignation of Non-Executive Director

Nufarm today announced the resignation of Toshikazu Takasaki as a Non-Independent Non-Executive Director of the Nufarm Board, effective 31 May 2022. Mr Takasaki joined the Nufarm Board on 6 December 2012 representing the interests of Sumitomo Chemical Company, Limited. Nufarm Chairman, John Gillam, said, “Takasaki-san has been a valued member of the Nufarm Board for ...

24 May 2022

Nufarm receives notification of sale of shares from Sumitomo

Nufarm has received notification overnight from Sumitomo Chemical Company Limited regarding its decision to sell its 15.9% shareholding in Nufarm. In 2010, Sumitomo Chemical acquired 20% of Nufarm’s outstanding shares and began a comprehensive business alliance with the company. The companies are currently generating major synergies in the development and sales of agricultural chemicals in ...

19 May 2022

Nufarm Half Year Results 2022

Nufarm delivers 41% growth in underlying earnings for 1H22 Overview Underlying EBITDA up 41% on the previous corresponding period (pcp) to $330 million on revenue of $2.2 billion, up 31% on pcp Statutory net profit after tax of $99 million, up 61% on pcp Underlying net profit after tax of $133 million, an increase of ...